510(k) Report

510(k) · Cleared

Cleared

Ivt 0.014 Track or Ivt 0.014 Accutrack

K954622510(k) TraditionalCleared Apr 29, 1996207-day reviewClass II21 CFR 870.1330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific /International Technologies · DQX Wire, Guide, Catheter

Cleared on Apr 29, 1996 as substantially equivalent to K895903 (Intensive Technology, Inc., 1990) and 1 other predicate after a 207-day review. Its family tree reaches back 1 generation to 1988.

Decided
Apr 29, 1996
Review
207 days
Class
Class II
Product code
DQX
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K882804 (1988). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1990: 1 other ancestorK882804 · 0.014 Peripheral Guide Wire · Intensive Technology, Inc. · 19881986198819901992199419961998
Other ancestors, by generation 1 generation back: 1 other ancestor K882804 · 0.014 Peripheral Guide Wire · Intensive Technology, Inc. · 19880
  1. Root · 1 generation backK882804 0.014 Peripheral Guide WireIntensive Technology, Inc. · 1988
  2. This deviceK954622 Ivt 0.014 Track or Ivt 0.014 AccutrackBoston Scientific /International Technologies · 1996
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K8828040.014 Peripheral Guide WireIntensive Technology, Inc.1988—
0 (this device)K954622Ivt 0.014 Track or Ivt 0.014 AccutrackBoston Scientific /International Technologies1996—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
FIG. 1 — Lineage of K954622, 1988–1996Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQX device

  1. #1 K213854 SavvyWirescore 15.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K895903Ivt 0.014 Guide Wire
Summary page 1
…res classified under 21 CFR 870.1330 PREDICATED DEVICES: IVT is claiming substantial equivalence to the following predicate medical devices: 1. IVT 0.014" Guidewire (K895903) 2. IVT 0.014" Peripheral Guidewire (K882804) 3. ACS 0.014" High Torque Floppy 4. Cook Family of Guidewires 1. DEVICE DESCRIPT…
Intensive Technology, Inc.1990—
*K8828040.014 Peripheral Guide Wire
Summary page 1
…TED DEVICES: IVT is claiming substantial equivalence to the following predicate medical devices: 1. IVT 0.014" Guidewire (K895903) 2. IVT 0.014" Peripheral Guidewire (K882804) 3. ACS 0.014" High Torque Floppy 4. Cook Family of Guidewires 1. DEVICE DESCRIPTION: The IVT 0.014" TRACK is constructed fro…
Intensive Technology, Inc.1988—
*—ACS 0.014" High Torque Floppy
Named without a submission number
—
*—Cook Family of Guidewires
Named without a submission number
—

Also cleared against K895903: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K895903.

How does its category compare?

All DQX devices

DQX Wire, Guide, Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQX

10in 2025

2007: 142008: 192009: 182010: 212011: 182012: 202013: 182014: 182015: 152016: 142017: 192018: 192019: 132020: 142021: 62022: 152023: 102024: 112025: 102026 (partial year): 12
2007high 21 (2010) · low 6 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQX

177in 2025

2007: 85 days median2008: 87 days median2009: 87 days median2010: 63 days median2011: 43 days median2012: 62 days median2013: 119 days median2014: 103 days median2015: 112 days median2016: 179 days median2017: 85 days median2018: 114 days median2019: 173 days median2020: 106 days median2021: 161 days median2022: 212 days median2023: 136 days median2024: 134 days median2025: 177 days median2026 (partial year): 145 days median
2007high 212 (2022) · low 43 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQX

3in 2024

2007: 122008: 72009: 492010: 342011: 32012: 52013: 7, 4 Class I2015: 12016: 2, 2 Class I2017: 172018: 92019: 22020: 1, 1 Class I2024: 32026 (partial year): 4, 1 Class I
2007high 49 (2009) · low 0 (2014)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · DQX

2,178in 2025

2007: 7602008: 7152009: 6872010: 9872011: 1,3112012: 1,3372013: 1,4742014: 1,3232015: 1,3232016: 1,4662017: 1,5242018: 1,7372019: 1,6792020: 1,5362021: 1,7132022: 1,6472023: 2,0682024: 2,2102025: 2,178
2007high 2,210 (2024) · low 687 (2009)2025

MAUDE reports naming product code DQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007148512760
200819877715
2009188749687
2010216334987
2011184331,311
2012206251,337
2013181197 (4)1,474
20141810301,323
20151511211,323
2016141792 (2)1,466
20171985171,524
20181911491,737
20191317321,679
2020141061 (1)1,536
2021616101,713
20221521201,647
20231013602,068
20241113432,210
20251017702,178
2026121454 (1)—

What is it indicated for?

The IVT 0.014" TRACK is intended to facilitate the navigation and placement of angioplasty and interventional devices through tortuous peripheral and coronary vessels.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K954622: Ivt 0.014 Track or Ivt 0.014 Accutrack.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K954622

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026